MedWatch

Demant has long-term expectations in China

With the 20-percent acquisition of a network of hearing aid clinics in China, Demant is making its long-term ambitions in the nation known. ”China will inevitably be the world’s second-biggest, if not the biggest, market for hearing aids,” CEO at Demant Søren Nielsen tells MarketWire.

Søren Nielsen, CEO of Demant | Photo: Kenneth Lysbjerg Koustrup/ERH

Hearing aid manufacturer Demant announced in beginning of March the acquisition of 20 percent of shares in Shengwang, a network of hearing aid clinics in China.

The company also said it was working on buying the remaining 80 percent of its long-standing partner, which is operating in the fast-growing Chinese market, before the end of H1 2022. There is no news on this front, says Søren Nielsen, CEO of Demant, in an interview with MarketWire.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs